Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2023-06-22 00:00:00 ET · period of report 2023-06-20 · accession 0001209191-23-039148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-22 | 2023-06-20 | NTLA | Clark Eliana | EVP, Chief Technical Off | M - OptEx | $12.27 | +5,000 | 50.1K | +11% | +$61.4K |
| D | 2023-06-22 | 2023-06-20 | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale+OE | $45.00 | -5,000 | 45.1K | -10% | -$225.0K |
| D | 2023-06-22 | 2023-06-20 | NTLA | Clark Eliana | EVP, Chief Technical Off | M - OptEx | $0.00 | -5,000 | 57.8K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-20 | M | A | 5,000 | $12.27 | 50,146 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-20 | S | D | 5,000 | $45.00 | 45,146 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2023-06-20 | M | D | 5,000 | $0.00 | 57,750 | D | $12.27 · — to 2030-02-02 | 5,000 Common Stock | (F2) The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested as to 64,062 shares as of June 20, 2023. |